Omega Therapeutics Inc (OMGA)
2.08
-0.16
(-7.14%)
USD |
NASDAQ |
Jun 28, 16:00
2.01
-0.07
(-3.37%)
After-Hours: 20:00
Omega Therapeutics Cash from Financing (Quarterly): -1.07M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.07M |
December 31, 2023 | 1.625M |
September 30, 2023 | -0.008M |
June 30, 2023 | 0.219M |
March 31, 2023 | 39.99M |
December 31, 2022 | 0.586M |
September 30, 2022 | 0.004M |
June 30, 2022 | 0.035M |
March 31, 2022 | 0.083M |
Date | Value |
---|---|
December 31, 2021 | 7.295M |
September 30, 2021 | 128.71M |
June 30, 2021 | 0.118M |
March 31, 2021 | 125.41M |
December 31, 2020 | 0.046M |
September 30, 2020 | 7.528M |
June 30, 2020 | 4.999M |
March 31, 2020 | 36.04M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.07M
Minimum
Mar 2024
128.71M
Maximum
Sep 2021
20.68M
Average
0.586M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
Altimmune Inc | -0.261M |
Macrogenics Inc | 0.248M |
Viking Therapeutics Inc | 606.04M |
vTv Therapeutics Inc | 50.14M |
Rhythm Pharmaceuticals Inc | 4.243M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -11.80M |
Cash from Investing (Quarterly) | 4.465M |
Free Cash Flow | -78.61M |
Free Cash Flow Per Share (Quarterly) | -0.2238 |
Free Cash Flow to Equity (Quarterly) | -11.35M |
Free Cash Flow Yield | -68.55% |